
Lawrence E. Crane
Examiner (ID: 9019, Phone: (571)272-0651 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1802, 1609, 1803, 1621, 1211, 1623, 1203 |
| Total Applications | 1975 |
| Issued Applications | 1276 |
| Pending Applications | 96 |
| Abandoned Applications | 610 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5436491
[patent_doc_number] => 20090171078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'METHOD OF SEQUENCING NUCLEIC ACIDS USING ELABORATED NUCLEOTIDE PHOSPHOROTIOLATE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/275176
[patent_app_country] => US
[patent_app_date] => 2008-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9178
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20090171078.pdf
[firstpage_image] =>[orig_patent_app_number] => 12275176
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/275176 | METHOD OF SEQUENCING NUCLEIC ACIDS USING ELABORATED NUCLEOTIDE PHOSPHOROTIOLATE COMPOUNDS | Nov 19, 2008 | Abandoned |
Array
(
[id] => 7724435
[patent_doc_number] => 08097706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-17
[patent_title] => 'Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein'
[patent_app_type] => utility
[patent_app_number] => 12/742367
[patent_app_country] => US
[patent_app_date] => 2008-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3576
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/097/08097706.pdf
[firstpage_image] =>[orig_patent_app_number] => 12742367
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/742367 | Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein | Nov 6, 2008 | Issued |
Array
(
[id] => 8214646
[patent_doc_number] => 08193339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'Synthesis of β-nucleosides'
[patent_app_type] => utility
[patent_app_number] => 12/266128
[patent_app_country] => US
[patent_app_date] => 2008-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4741
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193339.pdf
[firstpage_image] =>[orig_patent_app_number] => 12266128
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/266128 | Synthesis of β-nucleosides | Nov 5, 2008 | Issued |
Array
(
[id] => 5959546
[patent_doc_number] => 20110183933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'NOVEL MODULATORS OF CELL CYCLE CHECKPOINTS AND THEIR USE IN COMBINATION WITH CHECKPOINT KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/744021
[patent_app_country] => US
[patent_app_date] => 2008-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24789
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20110183933.pdf
[firstpage_image] =>[orig_patent_app_number] => 12744021
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744021 | Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors | Nov 4, 2008 | Issued |
Array
(
[id] => 6433226
[patent_doc_number] => 20100152281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS IN INDIVIDUALS HAVING SIGNIFICANTLY IMPAIRED RENAL FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/263239
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18614
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152281.pdf
[firstpage_image] =>[orig_patent_app_number] => 12263239
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/263239 | METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS IN INDIVIDUALS HAVING SIGNIFICANTLY IMPAIRED RENAL FUNCTION | Oct 30, 2008 | Abandoned |
Array
(
[id] => 9375808
[patent_doc_number] => 08680072
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Use of alginate oligomers in combating biofilms'
[patent_app_type] => utility
[patent_app_number] => 12/745058
[patent_app_country] => US
[patent_app_date] => 2008-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 10
[patent_no_of_words] => 16429
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12745058
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/745058 | Use of alginate oligomers in combating biofilms | Oct 23, 2008 | Issued |
Array
(
[id] => 6551464
[patent_doc_number] => 20100222565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'METHOD OF PRODUCING 2\'-DEOXY-5-AZACYTIDINE (DECITABINE)'
[patent_app_type] => utility
[patent_app_number] => 12/682293
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2895
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222565.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682293
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682293 | METHOD OF PRODUCING 2'-DEOXY-5-AZACYTIDINE (DECITABINE) | Oct 9, 2008 | Abandoned |
Array
(
[id] => 5285677
[patent_doc_number] => 20090099352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'SYNTHESIS OF OLIGONUCLEOTIDES OR PHOSPHOROTHIOATE OLIGONUCLEOTIDE WITH A CAPPING AGENT OF N-METHYLIMIDAZOLE FREE OF 1,3,5-TRIMETHYLHEXAHYDRO-1,3,5-TRIAZINE'
[patent_app_type] => utility
[patent_app_number] => 12/249538
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 1855
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099352.pdf
[firstpage_image] =>[orig_patent_app_number] => 12249538
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/249538 | Synthesis of oligonucleotides or phosphorothioate oligonucleotide with a capping agent of N-methylimidazole free of 1,3,5-trimethylhexahydro-1,3,5-triazine | Oct 9, 2008 | Issued |
Array
(
[id] => 6511744
[patent_doc_number] => 20100210833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'METHOD OF PRODUCING NUCLEOSIDES'
[patent_app_type] => utility
[patent_app_number] => 12/682325
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3052
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210833.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682325
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682325 | METHOD OF PRODUCING NUCLEOSIDES | Oct 9, 2008 | Abandoned |
Array
(
[id] => 6629895
[patent_doc_number] => 20100311681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'STABLE 6-METHOXY-2\',3\'-DIDEOXYGUANOSINE, METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/743898
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2346
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311681.pdf
[firstpage_image] =>[orig_patent_app_number] => 12743898
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/743898 | Stable 6-methoxy-2′,3′-dideoxyguanosine, method for preparing the same and pharmaceutical composition containing the same | Oct 9, 2008 | Issued |
Array
(
[id] => 8846281
[patent_doc_number] => 08455462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-04
[patent_title] => 'Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid'
[patent_app_type] => utility
[patent_app_number] => 12/681256
[patent_app_country] => US
[patent_app_date] => 2008-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 11813
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681256
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681256 | Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid | Oct 1, 2008 | Issued |
Array
(
[id] => 5453231
[patent_doc_number] => 20090069268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'NOVEL PHOSPHORAMIDATE COMPOUNDS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/236323
[patent_app_country] => US
[patent_app_date] => 2008-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 32170
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069268.pdf
[firstpage_image] =>[orig_patent_app_number] => 12236323
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/236323 | NOVEL PHOSPHORAMIDATE COMPOUNDS AND METHODS OF USE | Sep 22, 2008 | Abandoned |
Array
(
[id] => 5540002
[patent_doc_number] => 20090221807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => '2\' Deoxy-2\'-Alkylnucleotide Containing Nucleic Acid'
[patent_app_type] => utility
[patent_app_number] => 12/206672
[patent_app_country] => US
[patent_app_date] => 2008-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11456
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221807.pdf
[firstpage_image] =>[orig_patent_app_number] => 12206672
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/206672 | 2' Deoxy-2'-Alkylnucleotide Containing Nucleic Acid | Sep 7, 2008 | Abandoned |
Array
(
[id] => 204752
[patent_doc_number] => 07629328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-08
[patent_title] => 'Nucleoside derivatives for treating hepatitis C virus infection'
[patent_app_type] => utility
[patent_app_number] => 12/206581
[patent_app_country] => US
[patent_app_date] => 2008-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11888
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/629/07629328.pdf
[firstpage_image] =>[orig_patent_app_number] => 12206581
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/206581 | Nucleoside derivatives for treating hepatitis C virus infection | Sep 7, 2008 | Issued |
Array
(
[id] => 8968648
[patent_doc_number] => 08507459
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-13
[patent_title] => 'Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer'
[patent_app_type] => utility
[patent_app_number] => 12/676953
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3357
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12676953
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/676953 | Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer | Aug 20, 2008 | Issued |
Array
(
[id] => 6102599
[patent_doc_number] => 20110166092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'DOSING METHODS FOR TREATING DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/674136
[patent_app_country] => US
[patent_app_date] => 2008-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6894
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166092.pdf
[firstpage_image] =>[orig_patent_app_number] => 12674136
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/674136 | DOSING METHODS FOR TREATING DISEASE | Aug 18, 2008 | Abandoned |
Array
(
[id] => 4515951
[patent_doc_number] => 07910726
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-22
[patent_title] => 'Amidite for synthesizing modified nucleic acid and method for synthesizing modified nucleic acid'
[patent_app_type] => utility
[patent_app_number] => 12/181459
[patent_app_country] => US
[patent_app_date] => 2008-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 6253
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/910/07910726.pdf
[firstpage_image] =>[orig_patent_app_number] => 12181459
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/181459 | Amidite for synthesizing modified nucleic acid and method for synthesizing modified nucleic acid | Jul 28, 2008 | Issued |
Array
(
[id] => 4792694
[patent_doc_number] => 20080293668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => '[5-carboxamido or 5-fluoro]-[2\',3\'-unsaturated or 3\'-modified]-pyrimidine nucleosides'
[patent_app_type] => utility
[patent_app_number] => 12/220609
[patent_app_country] => US
[patent_app_date] => 2008-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8549
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293668.pdf
[firstpage_image] =>[orig_patent_app_number] => 12220609
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/220609 | [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides | Jul 24, 2008 | Abandoned |
Array
(
[id] => 8549490
[patent_doc_number] => 08324372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-04
[patent_title] => 'Polynucleotide capture materials, and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 12/172214
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13916
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12172214
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/172214 | Polynucleotide capture materials, and methods of using same | Jul 10, 2008 | Issued |
Array
(
[id] => 8555202
[patent_doc_number] => 08329674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Film forming dental compositions and related methods'
[patent_app_type] => utility
[patent_app_number] => 12/594988
[patent_app_country] => US
[patent_app_date] => 2008-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10077
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12594988
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/594988 | Film forming dental compositions and related methods | Jul 9, 2008 | Issued |